Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is cooperating with governmental entities in Europe in their respective investigations on the company’s Vioxx product.
Investigations are…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that As of September 30, 2009, the Company had been served or was aware that it had been named…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that as of June 30, 2009, the Company had been served or was aware that it had been named…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that the motion for rehearing en banc regarding the Texas state court case, Ernst v. Merck, was due on…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is responding to the subpoena sent by the State of California Attorney General in connection with company’s…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is cooperating with U.S. Attorney s Office for the District of Massachusetts.
In March 2009, Merck received a…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that in the MDL proceeding of the Vioxx dispute, the parties and the court have agreed that the Louisiana…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is cooperating with governmental entities in Europe in their respective investigations on the company’s Vioxx product.
Investigations are…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is cooperating with the U.S. Department of Justice regarding a probe centered on its Vioxx product activities.
The…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that on Feb. 11, 2009, the Company filed a reply on the rehearing motion on the Texas state court…